Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk
Source ↗
👁 2
💬 0
After winning the battle for injectable obesity medicines, Lilly hopes Foundayo can help it catch up in the oral market, where Novo has a three-month lead.
Comments (0)